Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
An Open-Label Study of Azetukalner in Major Depressive DisorderNCT06922110XENEPhase 3Enrolling by invitation2027-01Estimated
A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD)NCT06924970AGIOPhase 2Active not recruiting2026-05-12Actual
An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous UrticariaNCT06927999SPRYPhase 2Recruiting2027-06Estimated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)NCT06941844Definium Therapeutics US, Inc.Phase 3Active not recruiting2026-05-20Actual
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsNCT06943755ExelixisPhase 2, Phase 3Recruiting2029-06-30Estimated
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)NCT06951217AVLNPhase 2Recruiting2031-12-31Estimated
Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT06953466Quoin PharmaceuticalsPhase 2, Phase 3Recruiting2026-12-30Estimated
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric InsomniaNCT06953869Vanda PharmaceuticalsPhase 3Recruiting2027-11Estimated
STOP-HAE: A Phase 3 Study of ADX-324 in HAENCT06960213ADARx Pharmaceuticals, Inc.Phase 3Recruiting2027-11-30Estimated
Randomized Withdrawal Study in Patients With SchizophreniaNCT06961968Vanda PharmaceuticalsPhase 3Recruiting2027-11Estimated
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)NCT06963710Aligos TherapeuticsPhase 2Active not recruiting2027-03Estimated
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)NCT06966479UPBPhase 2Active not recruiting2027-09Estimated
Safety and Efficacy of VDPHL01 in Males With AGANCT06972264MANEPhase 3Active not recruiting2026-12Estimated
Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)NCT06973629Brainstorm-Cell TherapeuticsPhase 3Not yet recruiting2028-11-01Estimated
A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDNCT06979544LPCNPhase 3Completed2026-01-16Actual
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078UPBPhase 2Active not recruiting2027-10Estimated
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerNCT06982521RLAYPhase 3Recruiting2028-04-30Estimated
Atacicept in Multiple Glomerular DiseasesNCT06983028VERAPhase 2Recruiting2027-11Estimated
A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)NCT06985147IRONPhase 2Active not recruiting2027-02Estimated
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or OverweightNCT06987513ALTPhase 2Completed2026-07-30Actual
Phase 2 Study of ADX-038 in Complement-Mediated Kidney DiseaseNCT06989359ADARx Pharmaceuticals, Inc.Phase 2Recruiting2028-12-31Estimated
Phase 2 Study of ADX-038 in Participants With Geographic AtrophyNCT06990269ADARx Pharmaceuticals, Inc.Phase 2Recruiting2030-02-28Estimated
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKNCT06990399KODPhase 3Recruiting2027-04Estimated
A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS)NCT06990984Thiogenesis Therapeutics, Inc.Phase 2Not yet recruiting2027-06Estimated
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.NCT06991114ARTVPhase 2Recruiting2028-01Estimated
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting DefenseNCT06993610Zura Bio IncPhase 2Active not recruiting2026-11Estimated
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerNCT06995677TYRAPhase 2Recruiting2028-02Estimated
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLENCT06996080KODPhase 3Recruiting2027-02Estimated
Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic DermatitisNCT06998056ARQTPhase 2Completed2025-12-04Actual
Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)NCT06999902Praxis Precision MedicinesPhase 2, Phase 3Completed2026-05-14Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.